[
  {
    "entityType": "legalEntity",
    "foundingDate": "1992-06-17",
    "identifiers": [
      {
        "id": "02723534",
        "scheme": "GB-COH"
      },
      {
        "id": "PY6ZZQWO2IZFZC3IOL08",
        "scheme": "XI-LEI"
      }
    ],
    "jurisdiction": {
      "code": "GB",
      "name": "United Kingdom of Great Britain and Northern Ireland (the)"
    },
    "isComponent": false,
    "name": "AstraZeneca PLC",
    "publicListing": {
      "hasPublicListing": true,
      "companyFilingsURLs": [
        "https://www.londonstockexchange.com/stock/AZN/astrazeneca-plc/analysis",
        "https://www.astrazeneca.com/investor-relations/stock-exchange-announcements.html"
      ],
      "securitiesListings": []
    },
    "publicationDetails": {
      "bodsVersion": "0.4",
      "license": "https://creativecommons.org/licenses/by/2.0/legalcode",
      "publicationDate": "2021-02-09",
      "publisher": {
        "name": "Open Ownership",
        "url": "http://www.openownership.org"
      }
    },
    "source": {
      "description": "This information has been retrieved from diverse public sources.",
      "type": [
        "primaryResearch"
      ]
    },
    "statementDate": "2021-02-09",
    "statementID": "openo-es-00006565580581270044236",
    "statementType": "entityStatement"
  }
]
